STOCK TITAN

OrthoPediatrics corp - KIDS STOCK NEWS

Welcome to our dedicated news page for OrthoPediatrics (Ticker: KIDS), a resource for investors and traders seeking the latest updates and insights on OrthoPediatrics.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect OrthoPediatrics's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of OrthoPediatrics's position in the market.

Rhea-AI Summary
OrthoPediatrics Corp. to participate in fireside chat at the 23rd Annual Needham Virtual Healthcare Conference. Dave Bailey and Fred Hite to discuss advancements in pediatric orthopedics on April 9, 2024.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
10.15%
Tags
conferences
-
Rhea-AI Summary
OrthoPediatrics Corp. reports a record full-year 2023 revenue of $148.7 million, up 22% from the prior year. The company helped nearly 20,000 children in Q4 2023 and 82,000 in full-year 2023, with total assistance to over 710,000 kids. They generated $37.6 million in revenue in Q4 2023, a 21% increase from Q4 2022. OrthoPediatrics achieved record full-year adjusted EBITDA of $5.0 million in 2023 and launched 8 new products. The acquisition of Boston Orthotics & Prosthetics expanded their offerings. The company strengthened its balance sheet with an $80 million debt financing. They reiterated full-year 2024 revenue guidance of $197.0 million to $200.0 million, anticipating 32% to 34% growth compared to 2023.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.64%
Tags
earnings
-
Rhea-AI Summary
OrthoPediatrics Corp. announced the launch of the RESPONSE™ Rib and Pelvic Fixation system to treat children with Early Onset Scoliosis. This marks the company's 71st system for pediatric orthopedic conditions, providing implants and instruments for rib and pelvic fixation. The system offers a variety of implant options, low profile implants, rib hooks, and locking options. It is compatible with existing RESPONSE™ Systems, allowing comprehensive treatment for scoliosis patients.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.55%
Tags
none
Rhea-AI Summary
OrthoPediatrics Corp. (KIDS) has been named one of the 2024 Best Places to Work in Indiana for the 8th time. The company focuses on pediatric orthopedics and is committed to fostering a positive culture. OrthoPediatrics President & CEO looks forward to receiving detailed feedback to enhance the organization further.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.24%
Tags
none
-
Rhea-AI Summary
OrthoPediatrics Corp. to Release Q4 and Full Year 2023 Financial Results on March 6, 2024
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.14%
Tags
conferences earnings
-
Rhea-AI Summary
OrthoPediatrics Corp. (KIDS) issues 2024 financial guidance, reporting a 21% growth in net revenue for the fourth quarter of 2023 compared to the same period in 2022. The company expects to reach a net revenue of $148.7 million for the full year of 2023, with domestic net revenue growing by 20% and international net revenue growing by 26%. OrthoPediatrics also acquired Boston O&P, with a projected $197 million to $200 million revenue for 2024.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.45%
Tags
none
Rhea-AI Summary
OrthoPediatrics Corp. (Nasdaq: KIDS) has acquired Boston Orthotics & Prosthetics, a leader in pediatric orthotic management for over 50 years, and closed an $80 million debt financing with MidCap Financial. The acquisition expands OrthoPediatrics' Specialty Bracing division and provides leading technology and pediatric care through dedicated clinics. The transaction details include an upfront cash payment of $22 million, and OrthoPediatrics' cash and restricted cash balance post-closing is approximately $60 million.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.45%
Tags
acquisition
-
Rhea-AI Summary
OrthoPediatrics Corp. (Nasdaq: KIDS) announced the launch of its new division, OrthoPediatrics Specialty Bracing division (OPSB), focusing on non-surgical intervention for pediatric orthopedics. The division aims to expand the Company’s Total Addressable Market by approximately $600 million, following the acquisition of MD Orthopaedics, Inc. (MDO) and Rhino Pediatric Orthopedic Designs, Inc. The Company also introduced the DF2® Brace and partnered with Ora Medical to distribute The Levity, a gait-trainer device for children with walking difficulties.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.44%
Tags
none
-
Rhea-AI Summary
OrthoPediatrics Corp. (Nasdaq: KIDS) increases its support of IPOS as an Emerald-Level sponsor, showcasing its expanding product portfolio at the event. Over 500 pediatric orthopedic surgeons are registered to attend the meeting from December 5-9, in Orlando, Florida. The company aims to connect with its surgeon customers and continue to partner with them in education, emphasizing its commitment to advancing the field of pediatric orthopedics.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.77%
Tags
conferences
Rhea-AI Summary
OrthoPediatrics Corp. (NASDAQ: KIDS) announces participation in fireside chats at Stifel 2023 Healthcare Conference and Piper Sandler 35th Annual Healthcare Conference. The company's President & CEO and COO/CFO will discuss at the events, with audio webcasts and replays available online at the OrthoPediatrics investor relations website.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.67%
Tags
conferences
OrthoPediatrics corp

Nasdaq:KIDS

KIDS Rankings

KIDS Stock Data

686.70M
15.98M
32.28%
71.91%
4%
Ophthalmic Goods Manufacturing
Manufacturing
Link
US
Warsaw

About KIDS

orthopediatrics is the worldwide leader in pediatric orthopedics. we are the first company whose total focus is helping children with orthopaedic conditions and injuries by providing the surgeons who care for them with anatomically appropriate implants. every day, we focus purely on advancing the field of pediatric orthopedics through the innovative development of state-of-the-art technologies, commitment to quality products, and industry-leading support and clinical education with our experienced team of experts. our offering is continuing to expand as we strive to develop all of the necessary implants and instruments that a pediatric orthopedic surgeon needs to treat his/her patients, including: long bone deformity correction & trauma, spine, and sports medicine. as we continue to grow, we are looking for talented professionals to join our cause! visit our website to learn more about current openings, or submit a resume to careers@orthopediatrics.com!